Metropolitan Life Insurance CO C4 Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $4,575 - $13,313	-1,476 Reduced 57.14%	1,107 $3,000
Q4 2022 Jun 14, 2023	BUY	$5.42 - $10.24 $7,999 - $15,114	1,476 Added 133.33%	2,583 $15.2 Million
Q3 2022 Jun 14, 2023	BUY	$8.03 - $12.77 $11,852 - $18,848	1,476 Added 133.33%	2,583 $22.7 Million
Q2 2022 Jun 20, 2023	BUY	$5.06 - $26.46 $7,468 - $39,054	1,476 Added 133.33%	2,583 $19,000
Q1 2022 Jun 20, 2023	BUY	$19.99 - $33.23 $29,505 - $49,047	1,476 Added 133.33%	2,583 $62,000
Q1 2022 Mar 30, 2023	SELL	$19.99 - $33.23 $155,762 - $258,928	-7,792 Reduced 75.1%	2,583 $62,000
Q1 2022 May 12, 2022	SELL	$19.99 - $33.23 $155,762 - $258,928	-7,792 Reduced 75.1%	2,583 $63,000
Q4 2021 Jun 21, 2023	BUY	$29.39 - $46.86 $272,386 - $434,298	9,268 Added 837.22%	10,375 $334,000
Q3 2021 Jun 21, 2023	BUY	$35.91 - $50.5 $332,813 - $468,034	9,268 Added 837.22%	10,375 $463,000
Q3 2021 Mar 30, 2023	BUY	$35.91 - $50.5 $6,356 - $8,938	177 Added 1.74%	10,375 $463,000
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $6,356 - $8,938	177 Added 1.74%	10,375 $464,000
Q2 2021 Jun 21, 2023	BUY	$30.39 - $42.18 $276,275 - $383,458	9,091 Added 821.23%	10,198 $385,000
Q2 2021 Mar 30, 2023	BUY	$30.39 - $42.18 $196,349 - $272,524	6,461 Added 172.89%	10,198 $385,000
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $309,795 - $429,982	10,194 Added 254850.0%	10,198 $386,000
Q1 2021 Jun 26, 2023	BUY	$31.96 - $46.5 $84,054 - $122,295	2,630 Added 237.58%	3,737 $138 Million
Q1 2021 May 14, 2021	SELL	$31.96 - $46.5 $119,306 - $173,584	-3,733 Reduced 99.89%	4 $138,000
Q4 2020 Jun 22, 2023	BUY	$22.8 - $37.05 $59,964 - $97,441	2,630 Added 237.58%	3,737 $123,000
Q4 2020 Mar 30, 2023	BUY	$22.8 - $37.05 $26,311 - $42,755	1,154 Added 44.68%	3,737 $123,000
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $85,203 - $138,455	3,737 New	3,737 $124,000

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

Lynx1 Capital Management LP San Juan, PR

6.88M
Shares

$30.1 Million
14.04% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

6.6M
Shares

$28.9 Million
3.2% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

5.68M
Shares

$24.9 Million
0.16% of portfolio
Ra Capital Management, L.P. Boston, MA

4.88M
Shares

$21.4 Million
0.39% of portfolio
Black Rock Inc. New York, NY

4.55M
Shares

$19.9 Million
0.0% of portfolio

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account